Weidan Ji

Second Military Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index1.6kcitations50works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(15), MicroRNA in disease regulation(10), Cancer-related molecular mechanisms research(9), RNA modifications and cancer(9), Cancer Research and Treatments(9)

Publications50 total

Establishment and validation of a prediction model for myocarditis in Chinese children below 14 years old: a protocol for a retrospective cohort study
BMJ Open·2023· 2 citedOpen Access
Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
Frontiers in Genetics·2023· 12 citedOpen Access
[Genetic analysis of a Chinese pedigree affected with Congenital coagulation factor XII deficiency due to a c.1A>G start codon variant of F12 gene].
PubMed·2023
Data from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S3 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S2 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Conflict of Interest Form from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Conflict of Interest Form from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S1 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S2 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S1 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Data from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S3 from An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
2023Open Access
A novel matrine derivative, WM130, inhibits activation and movement of human hepatic stellate LX-2 cells by targeting cofilin 1
Cytotechnology·2022· 6 citedOpen Access
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
Journal for ImmunoTherapy of Cancer·2022· 18 citedOpen Access
<scp>miR</scp>‐2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting <scp>JAG2</scp>
Liver International·2022· 18 cited
A novel matrine derivative, WM130, inhibits activation and movement of human hepatic stellate LX-2 cells by targeting cofilin 1
Research Square (Research Square)·2022· 1 citedOpen Access
LncRNA CCAT1 Upregulates ATG5 to Enhance Autophagy and Promote Gastric Cancer Development by Absorbing miR-140-3p
Digestive Diseases and Sciences·2021· 40 cited
MicroRNA-2392 Functions as a Tumor Suppressor Gene and Inhibits Malignant Progression of Hepatocellular Carcinoma via Directly Targeting JAG2
Research Square (Research Square)·2021Open Access
LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1
Frontiers in Oncology·2021· 20 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Changqing Su(44), Zhangxiao Peng(21), Mengchao Wu(18), Bin Sun(16), Yinghan Su(16), Haihua Qian(12), Xuejing Lin(10), Bin Sun(10), Xiaoya Li(9), Chunying Liu(8), Yang Xu(8), Yang Xu(6), Longlong Bao(6), Shuwen Shen(6), Yang Xu(6), Lei Chen(6), Xiaoya Li(5), Zhigang Li(5), Gaoya Xu(4), Chunguang Li(4)